BioNexus Gene Lab Corp. BGLC
0.68 USD -0.05 (-7.29%)
Regular-session close
0.68 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
0.6586 Day range 0.753
0.6586 52-week range 4.97
- YTD
- -82.78%
- 1 year
- -85.80%
BGLC revenue history
Revenue is income from the company’s ordinary business activities.
7,424,911 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 7,424,911 | -2,085,735 | -21.93% |
| FY 2024 | 2024-12-31 | 9,510,646 | -260,160 | -2.66% |
| FY 2023 | 2023-12-31 | 9,770,806 | -1,157,901 | -10.60% |
| FY 2022 | 2022-12-31 | 10,928,707 | -2,433,860 | -18.21% |
| FY 2021 | 2021-12-31 | 13,362,567 | 1,972,127 | 17.31% |
| FY 2020 | 2020-12-31 | 11,390,440 | 11,263,485 | 8872.03% |
| FY 2019 | 2019-12-31 | 126,955 | -85,373 | -40.21% |
| FY 2018 | 2018-12-31 | 212,328 | 104,648 | 97.18% |
| FY 2017 | 2017-12-31 | 107,680 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
